Palonosetron Hydrochloride Injection, Solution
Product Images NDC 0781-3312

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Palonosetron Hydrochloride (NDC 0781-3312). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Palonosetron 01

FDA Label Image

Palonosetron 02

FDA Label Image

Palonosetron 03

FDA Label Image

Palonosetron 04

FDA Label Image

Palonosetron 05

Palonosetron 05
This is a description of Palonosetron HCI injection, which comes in a 5mL single-dose vial with a strength of 0.5mg/ml. The injection is for intravenous use only and contains Palonosetron hydrochloride, citric acid monohydrate, edetate disodium dihydrate, and water for injection. It is distributed by Sandoz and is indicated for use in adults to prevent nausea and vomiting caused by chemotherapy. The package insert should be consulted for dosage and administration information. It should be stored between 20°to 25° (66°to 77°F), and unused portions should be discarded. It is sterile and should be kept out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.